Latest Form 4 insider transactions

NASDAQ
Daniel J Stauber, a Director of Hawkins Inc, received 721 shares of common stock on July 29, 2026.
NASDAQ
Lee Flowers, SVP of Business Development of HCW Biologics Inc., purchased 7,736 shares of common stock on July 29, 2026 for $2.58 per share.
NASDAQ
Chris Lavern Reed, a Director of Byrna Technologies Inc., reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Jonathan Siegal, Principal Accounting Officer of Vericel Corp, sold 4,500 shares of common stock on July 30, 2026 for $48.90 per share.
NASDAQ
R. Michael Clemmer, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
James T Thompson, a Director of Hawkins Inc, received 721 shares of common stock on July 29, 2026.
NASDAQ
Adam L. Roth, a Director of Byrna Technologies Inc., reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Dennis N Berman, a Director of Inhibikase Therapeutics, Inc., reported multiple transactions in common stock on July 30, 2026.
NYSE
Charles D Lischer, SVP, CAO and Interim CFO of Graphic Packaging Holding Co, received 44,131 shares of common stock on July 29, 2026.
NASDAQ
Pc Nelson Griggs, Pres. Capital Access Platforms of Nasdaq, Inc., sold 11,010 shares of common stock on July 29, 2026 for $96.35 per share.
NYSE
Conor Fennerty, EVP, CFO & Treasurer of Curbline Properties Corp., sold 55,105 shares of common stock on July 30, 2026 for $30.38 per share.
NASDAQ
Lee Shavel, Chief Executive Officer and a Director of Verisk Analytics, Inc., sold 2,500 shares of common stock on July 29, 2026 for $220.00 per share.
NYSE
Joel Unruch, General Counsel/Corp Secretary of Accenture plc, sold 10,498 shares of common stock on July 30, 2026.
NASDAQ
Holly Beth Paeper, a Director of Littelfuse Inc /De, received 56 shares of common stock on July 30, 2026.
NASDAQ
Alan J Hyatt, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Kevin Charles Gallagher, a Director of Umb Financial Corp, sold 360 shares of common stock on July 31, 2026 for $145.13 per share.
Paul Beswick, SVP, Chief Information Officer of Marsh & Mclennan Companies, Inc., sold 713 shares of common stock on July 29, 2026 for $198.00 per share.
NYSE
Mark Martinelli, a Director of Chain Bridge Bancorp Inc, purchased 400 shares of common stock on July 29, 2026 for $44.00 per share.
NASDAQ
Scott T Garrett, a Director of HCW Biologics Inc., purchased 7,736 shares of common stock on July 29, 2026 for $2.58 per share.
NASDAQ
Louis P Jenkins Jr, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
David S. Jones, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
John Lamon, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Rebecca Middleton Mcdonald, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NASDAQ
Edward Lawrence Sanders Iii, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NYSE
Modine Manufacturing Company discussed Q1 2026 results and progress on the Gentherm merger during their July 30, 2026 earnings call.
NYSE
Castillo Cacho Guillermo Del, ENERGY MANAGER of Vesta Real Estate Corporation, S.A.B. de C.V., sold 1,675 shares of common stock on July 30, 2026 for $3.41 per share.
NASDAQ
Konrad Wayson, a Director of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.
NYSE
Saba Capital Management, L.P. reported changes in beneficial ownership of Mexico Fund Inc common stock on July 29, 2026.
NYSE
Edward F. Callahan, VP-Engineering of Badger Meter Inc, purchased 751 shares of common stock on July 30, 2026 for $135.25 per share.
NASDAQ
Charles S Cullum, EVP, Chief Financial Officer of Shore Bancshares Inc, reported multiple transactions in common stock on July 29, 2026.